(A) Fluorescence photomicrograph illustrating the bilateral injection in the ACA of a viral vector expressing inhibitory DREADD (hM4D Gi) fused with mCitrine. (B) Pharmacogenetic inhibition of the …
Spreadsheet of raw values for panels (B) and (C).
Animals received unilateral deposit of a retrograde tracer (Fluoro Gold) in the ACA (n=6, A).After 7 days, animals were exposed to the cat (PET, B) and perfused 90 min after. (C) Bar chart presents, …
Spreadsheet of raw values for panel (C).
Animals received unilateral deposit of a retrograde tracer (Fluoro Gold) in the ACA (n=6, A).After 7 days, animals were exposed to the cat (PET) and 24 hr later to the Predatory Context (B) and …
Spreadsheet of raw values for panel (C).
(A) Schematics showing the location of the bilateral AAV viral vector injection in the anteromedial thalamic nucleus (AM) and the position of bilateral optical fibers implanted in the ACA. (B) …
Spreadsheet of raw values for panel (E).
(A) Fluorescence photomicrograph illustrating the bilateral injection in the ACA of a viral vector expressing halorhodopsin-3.0 (eNpHR3.0) fused with mCherry. (B) Schematic drawing (center) and …
Behavior data – spreadsheet of raw values for panels (D) and (F).
Cell counting – spreadsheet of raw values for panels (E) and (G).
(A) Schematic drawing illustrating the bilateral injection in the ACA of a viral vector expressing halorhodopsin-3.0 (eNpHR3.0) fused with mCherry. (B) Schematic drawing (center) and fluorescence …
Behavior data – spreadsheet of raw values for panels (D) and (F).
Cell counting – spreadsheet of raw values for panels (E) and (G).
(A) Schematic drawing illustrating the bilateral injection in the ACA of a viral vector expressing halorhodopsin-3.0 (eNpHR3.0) fused with mCherry. (B) Schematic drawing (center) and fluorescence …
Behavior data – spreadsheet of raw values for panels (D) and (F).
Cell counting – spreadsheet of raw values for panels (E) and (G).
(A) Schematic drawing illustrating the bilateral injection in the ACA of a viral vector expressing halorhodopsin-3.0 (eNpHR3.0) fused with mCherry. (B) Schematic drawing (left) and fluorescence …
Behavior data – spreadsheet of raw values for panels (D) and (F).
Cell counting – spreadsheet of raw values of panels (E) and (G).
On the left, drawings to illustrate the experimental conditions PET (predator exposure test), Context (real cat related context), PCE (plush cat exposure), and PCC (plush cat context). On the right, …
(A) Representative traces of resting membrane potential from hM4D− neurons (control – upper panel) or hM4D+ neurons (lower panel). hM4D+ neurons hyperpolarized as they underwent extracellular CNO. …
(A) Representative trace of membrane potential from an HR+ neuron. The arrows and bars represent the light on and off, respectively. The percentage on the top of the panel indicates the intensity of …
(A) Representative EPSC traces before and after illumination at 585 nm (25 μW) with the arrows marking the stimulation (stimulus artifact). The upper traces show that there was no rebound excitation …
(A) Fluorescence photomicrograph illustrating the extent and location of unilateral viral injection in the ACA. (B–E) On the left, schematic drawings from the Allen Mouse Brain Atlas to indicate the …
Upper panel: Corrected total field fluorescence (CTFF) values for the cases 70, 71, and 72 showing the CTFF values for the ACA terminal fields to the BAL, POST, PERI, and PAGdl in a selected case …
Upper panel: Fluorescence photomicrographs illustrating the extent and location of unilateral Fluoro Gold deposit in the BLA (A), AAV-Retro-Ef1a-mcherry-IRES-Cre deposit in the PAGdl (B), and …
Fluorescence photomicrographs illustrating the optic fiber position in five experiments of the group HR+ that received optogenetic silencing of the ACA>POST pathway during cat exposure. Note that in …
Video to illustrate the behavioral responses of a male mice (C57BL/6) exposed to the cat (PET condition) and the predator-associated environment (Context condition).
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Strain, strain background (Mus musculus) | C57BL/6 | Local breeding facilities | ||
Strain, strain background (Felis catus) | Male cat | Domestic | ||
Transfected construct(adeno-associated virus) | AAV5-hSyn-HA-hM4D(Gi)-IRES-mCitrine | Addgene plasmid #50464(RRID: Addegene_50464) | Dr. Bryan Roth; titer≥7×10¹² vg/ml | |
Transfected construct (adeno-associated virus) | AAV5- hSyn-eGFP | Addgene viral prep #50465 | Dr. Bryan Roth; titer≥7×10¹² vg/ml | |
Transfected construct(adeno-associated virus) | AAV5-hSyn-eNpHR3-mCherry | University of North Carolina, Vector Core | Titer ≥1×10¹³ vg/ml | |
Transfected construct(adeno-associated virus) | AAV5-hSyn-mCherry | University of North Carolina, Vector Core | Titer ≥7×1012 vg/ml | |
Transfected construct(adeno-associated virus) | AAV-Retro-Ef1a-mcherry- IRES-Cre | Addgene catalog #55632-AAVrg | Karl Deisseroth; Titer ≥7×10¹² vg/ml | |
Antibody | (Polyclonal rabbit anti-c-Fos) | PC-38; Calbiochem-Millipore (RRID:AB_2106755) | (1:20,000) | |
Antibody | (Polyclonal anti-rabbit Alexa 594 goat IgG) (H+L) | Invitrogen (RRID:AB_2534079) | (1:500) | |
Antibody | (Polyclonal rabbit anti-FG antibody) | Chemicon International, CA | (1:5000) | |
Antibody | (Polyclonal anti-rabbit Alexa 488 Goat IgG) (H+L) | Invitrogen (RRID:AB_143165) | (1:1000) | |
Antibody | (Polyclonal anti-rabbit Alexa 405 goat IgG) (H+L) | Invitrogen (RRID:AB_221605) | (1:500) | |
Antibody | (Polyclonal goat anti-CTb) | List Biological Laboratories, Campbell, CA | (1:20,000) | |
Antibody | (Polyclonal anti-goat Alexa 488 donkey IgG) (H+L) | Invitrogen (RRID:AB_2534102) | (1:500) | |
Chemical compound, drug | Fluoro Gold | Fluorochrome Inc, CO | FG | |
Chemical compound, drug | Isoforine | Cristália Laboratories, SP, Brazil | ||
Chemical compound, drug | Clozapine-N-oxide | Tocris Bioscience, UK | CNO | |
Chemical compound, drug | Subunit B of the cholera toxin | List Biological Laboratories, Campbell, CA | CTb | |
Software, algorithm | Fiji | https://imagej.net/software/fiji/ (RRID:SCR_002285) | ||
Software, algorithm | BORIS software | DOI: 10.1111/2041–210X.12584 (RRID:SCR_021434) | Behavior Observation Research Interactive Software | |
Software, algorithm | pClamp 10.7 | Molecular Devices, USA (RRID:SCR_011323) | ||
Software, algorithm | Clampfit 10.7 | Molecular Devices, USA | ||
Software, algorithm | CorelDraw 2018 | https://www.coreldraw.com/br/pages/coreldraw-2018/ (RRID:SCR_014235) | ||
Software, algorithm | Statistica 7.0 | StatSoft (RRID:SCR_014213) | ||
Other | DAPI | Sigma-Aldrich | 1:20,000 |
Predator exposure test (PET) | Context | |||
---|---|---|---|---|
Male | Female | Male | Female | |
Freezing | 102.8±4.1 | 98.2±5.5 | 0±0 | 0±0 |
Risk assessment | 107.6±3.5 | 110.9±6.2 | 161.6±8.2 | 162.8±6.9 |
Exploration | 25.8±2.5 | 31.9±3.0 | 37.9±4.4 | 34.7±5.2 |
ACA – Pharmaco inhibition | AM>ACA Opto inhibition | |||||||
---|---|---|---|---|---|---|---|---|
Phase | GROUP | PET_Esc | CONT_Esc | Phase | GROUP | PET_Esc | Cont_Esc | |
Acquisition | hM4D+ | 1.57±0.3 | 0.43±0.2 | Acquisition | HR+ | 1.5±0.28 | 0.5±0.26 | |
Acquisition | hM4D− | 1.67±0.21 | 0.33±0.33 | Acquisition | HR− | 1.43±0.3 | 0.43±0.2 | |
Expression | hM4D+ | 1.57±0.3 | 0.57± 0.2 | |||||
Expression | hM4D− | 1.6±0.4 | 0.4±0.24 | |||||
ACA>BLA Opto inhibition | ACA>PERI Opto inhibition | |||||||
Phase | GROUP | PET_Esc | CONT_Esc | Phase | GROUP | PET_Esc | CONT_Esc | |
Acquisition | HR+ | 1.5±0.26 | 0.37±0.18 | Acquisition | HR+ | 1.66±0.33 | 0.16±0.16 | |
Acquisition | HR− | 1.33±0.21 | 0.33±0.21 | Acquisition | HR− | 1.4± 0.24 | 0.4±0.24 | |
Expression | HR+ | 1.28±0.18 | 0.5±0.27 | Expression | HR+ | 1.5±0.22 | 0.16±0.16 | |
Expression | HR− | 1.5±0.34 | 0.33±0.21 | Expression | HR− | 1±0 | 0.2±0.19 | |
ACA>POST Opto inhibition | ACA>PAG Opto inihibition | |||||||
Phase | GROUP | PET_Esc | CONT_Esc | Phase | GROUP | PET_Esc | CONT_Esc | |
Acquisition | HR+ | 1.33±0.21 | 0±0 | Acquisition | HR+ | 1.43±0.14 | 0.14±0.14 | |
Acquisition | HR− | 1.2±0.37 | 0.4±0.24 | Acquisition | HR− | 1.4±0.24 | 0.2±0.22 | |
Expression | HR+ | 1.16±0.18 | 0.33±0.18 | Expression | HR+ | 1.5±0.24 | 0.33±0.23 | |
Expression | HR− | 1.2±0.19 | 0±0 | Expression | HR− | 1±0 | 0.2±0.19 |